June 5, 2009 – MEDRAD Inc. has launched Manage.Report, an informatics application that enables healthcare professionals to access clinical and administrative information associated with radiology patients’ contrast injections from nearly anywhere.
The solution is designed to enable healthcare professionals to more immediately identify, validate and respond to clinical and administrative information, and it marks the first in the company’s series of informatics platform applications, and radiology imaging’s premier browser-based informatics solution.
Manage.Report automatically captures and logs in a secure database essential patient and radiology-management information concerning contrast injections delivered by the MEDRAD Stellant® CT injector. In addition to meeting the needs of clinical teams through immediate access to patient-specific injection information, Manage.Report automates record keeping, increases data accuracy, simplifies the audit process and facilitates compliance with the Joint Commission. RIS/PACS integration and remote service extensions are under development for the informatics solution, a platform based on service-oriented architecture and flexible design.
“Whether focusing on improved patient care, consistency in outcomes or increasing productivity, Manage.Report removes barriers to accessing the information that evidence-based decision making demands,” says Anthony Cinalli, executive director, Radiology Marketing. “Healthcare professionals can identify need and determine the course of action by analyzing robust clinical and administrative data sets they choose to monitor.”
Manage.Report automatically captures procedure information in a secure database. Within moments after the scan, radiologists can log in and review details on the actual protocols administered to their patients and consider injection specifics associated with the procedure such as pressure rates and flow graphs. Administrators can track procedure volumes, contrast usage and injection events, and conduct detailed analysis using robust, customized reporting capabilities.
For more information: www.medrad.com
March 06, 2024 
